Dr Alexandre Alanio is an M.D., Ph.D., expert in medical mycology and medical parasitology. He is currently Associate Professor in Paris VII University (Saint Louis Hospital, Paris, France), Permanent Researcher in the molecular mycology unit and Collaborator of the French National Reference Center for Mycoses and Antifungals.
He received his M.D. from Paris V university medical and its Ph.D. from Paris VII University. He owns more than 70 international publications and 4 international patents. He is currently teaching at the Paris VII Medical University for medical students, at the Paris Sorbonne Paris Cité Master I Microbiology course (IMVI), and at the Medical Mycology Course of the Institut Pasteur.
He is interested in dormancy and metabolism in Fungi, in particular in Cryptococcus neoformans and in pathophysiology of invasive fungal infections. He aims at bridging medical mycology with basic research on the pathophysiology of invasive fungal infections and translating new biological tools (bench) into diagnostic test for fungal and parasitic infections (bedside).
He is currently a partner in the InfectERA 2015 CryptoView project (PI: Uwe Himmelreich) and responsible for a microbiology substudy in the large EDTCP funded Ambition clinical trial (PI: Joe Jarvis, Tom Harrison).
On the bedside, he is actively working on the development of new molecular diagnostic tools for pneumocystosis, histoplasmosis, mucormycosis, aspergillosis, and other mold infections. He is also interested in the molecular epidemiology of antifungal resistance in clinically relevant fungi, in particular Aspergillus fumigatus or Candida glabrata. He recently published the ECIL-5 recommandation for the diagnosis of pneumocystosis in hematology patients and is part of different international working groups including the ISHAM Aspergillus resistance working group, the Fungal PCR Initiative (ISHAM), European Confederation of medical mycology (ECMM) excellence centers . He is fellow of and study coordinator for the ECMM and member of ECCMID, ISHAM and ASM societies. He is currently associate editor for New Microbes and New infections and for Journal of Clinical Microbiology (ASM) and Frontiers in cellular and infection Microbiology.